Your search returned 805 matches
First 10 records
Letter to FDA Praising Food Safety Cautiousness, Attacking Drug Safety Recklessness (HRG Publication #1903)
In contrast to becoming more active and cautious in enhancing food safety by removing potentially dangerous products before they have caused harm, several FDA decisions in the past year regarding prescription drugs can only be described as reckless.
[Created on: 03/08/2010]
Medical Malpractice Payments Fall Again in 2009
Medical Malpractice Payments Fall Again in 2009
[Created on: 03/03/2010]
Article in Health Matrix: Survey of State Medical and Osteopathy Board Disciplinary Web Sites in 2006
(HRG Publication #1902)
We sought to describe doctor disciplinary information provided
on the web sites of state medical and osteopathic boards. Information
collected included state board, hospital and federal government
actions, as well as malpractice judgments and settlements and conviction
information.
[Created on: 02/04/2010]
Open Letter to Executive Director of the Accreditation Council of Graduate Medical Education (ACGME) (HRG Publication #1901)
We encourage the ACGME to adopt the IOM's resident work hour limit recommendations.
[Created on: 01/28/2010]
Petition to Ban Fibromyalgia Drug Milnacipran (Savella) (HRG Publication #1900)
Milnacipran (Savella) has highly questionable clinical efficacy and has been associated with a large number of potentially serious adverse reactions including hypertension, increased heart rate and an increased incidence of suicidal ideation.
[Created on: 01/19/2010]
Liability Limits in Texas Fail to Curb Medical Costs
Texas Experiment With Medical Liability Caps Has Failed,
New Report Shows
[Created on: 12/17/2009]
Rewarding Failure: 10 Wall Street Firms that failed or took Bailout Money Paid their CEOs An Average of $28.9 Million a Year This Decade
Rewarding Failure: 10 Wall Street Firms that failed or took Bailout Money Paid their CEOs An Average of $28.9 Million a Year This Decade
[Created on: 12/14/2009]
Testimony: Issues in Clinical Trials of New Drugs for Community-Acquired Bacterial Pneumonia
(HRG Publication #1899)
The draft guidance under discussion clarifies several important issues regarding the appropriate design and conduct of noninferiority (NI) trials for community-acquired bacterial pneumonia (CABP).
[Created on: 12/10/2009]
Investments in the Opponents of Reform
Investments in the Opponents of Reform
[Created on: 12/08/2009]
Petition to Ban Sibutramine (Meridia) (HRG Publication #1898)
This purpose of this letter is to re-petition the FDA to immediately ban the weight loss drug, sibutramine (Meridia – Abbott – in the U.S.).
[Created on: 12/02/2009]
| Next 10>> |